Menu Search
Equities

Thermo Fisher Scientific Inc

TMO:NYQ

Thermo Fisher Scientific Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)612.84
  • Today's Change1.67 / 0.27%
  • Shares traded460.71k
  • 1 Year change+18.88%
  • Beta0.7788
Data delayed at least 15 minutes, as of Sep 16 2024 18:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy7
Outperform14
Hold8
Sell0
Strong Sell0

Share price forecast in USD

The 24 analysts offering 12 month price targets for Thermo Fisher Scientific Inc have a median target of 639.47, with a high estimate of 700.00 and a low estimate of 565.00. The median estimate represents a 4.63% increase from the last price of 611.17.
High14.5%700.00
Med4.6%639.47
Low-7.6%565.00

Dividends in USD

In 2023, Thermo Fisher Scientific Inc reported a dividend of 1.35 USD, which represents a 16.38% increase over last year. The 12 analysts covering the company expect dividends of 1.48 USD for the upcoming fiscal year, an increase of 9.78%.
Div growth (TTM)16.38%
More ▼

Earnings history & estimates in USD

On Jul 24, 2024, Thermo Fisher Scientific Inc reported 2nd quarter 2024 earnings of 5.37 per share. This result was in line with the consensus of the 20 analysts following the company and exceeded last year's 2nd quarter results by 4.27%.
The next earnings announcement is expected on Oct 23, 2024.
Average growth rate+1.34%
Thermo Fisher Scientific Inc reported annual 2023 earnings of 21.55 per share on Jan 31, 2024.
Average growth rate+18.01%
More ▼

Revenue history & estimates in USD

Thermo Fisher Scientific Inc. had 2nd quarter 2024 revenues of 10.54bn. This bettered the 10.51bn consensus of the 19 analysts covering the company. This was 1.58% below the prior year's 2nd quarter results.
Average growth rate-0.30%
Thermo Fisher Scientific Inc. had revenues for the full year 2023 of 42.86bn. This was 4.58% below the prior year's results.
Average growth rate+14.45%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.